Industry Consolidation

A Closer Look at the Most Recent Pfizer Acquisition Deal: Seagen Inc

March 15, 2023 - Recently, Pfizer Inc, a leading pharmaceutical manufacturer in the United States, confirmed plans to acquire Seagen, a smaller manufacturer focused on oncology medications, to expand its oncology portfolio, Pfizer Oncology. The recent acquisition deal is valued at about $43 billion, with each share amounting to $229 in cash. The deal is expected to be completed or finalized by the end...

Read More


More Articles

Senator Targets Amgen and Indivior Acquisitions for Antitrust Action

by Hayden Schmidt

Last week, the Senator from Massachusetts, Elizabeth Warren, penned a letter to the Federal Trade Commission (FTC) where she characterized recent consolidation in the pharmaceutical industry as a...

Reimagining the Global Pharmaceutical Supply Chain

by Veronica Salib

Workforce optimization, compliance challenges, and supply chain disruptions are all issues that plague the global pharmaceutical supply chain — an essential part of the healthcare system. Because global pharmaceutical supply chain...

GSK Introduces Standalone Consumer Healthcare Company, Haleon

by Samantha McGrail

GSK recently announced that the consumer healthcare company from its proposed transaction with Pfizer will be named Haleon. Haleon will be a new world leader in consumer healthcare, offering to bring...

Big Pharma Cooperation Advances Digital Measures, Drug Development

by Samantha McGrail

As big pharma looks to advance its pipelines of innovative drugs and digital measures, industry cooperation is crucial. In recent years, pharmaceutical companies have embraced a more collaborative way...

Pharmaceutical Supply Chain Increases Outpatient Drug Costs

by Samantha McGrail

A recent PhRMA report found that the cost of provider-administered medicines is significantly inflated by various aspects in the pharmaceutical supply chain, including coinsurance, HOPDs, and hospital...

Recent Articles